Access to POEMs and Essential Evidence Plus will no longer be included in CMA membership as of Dec. 1, 2023.
Clinical Question
Does it matter what time of day a person takes warfarin?
Bottom line
In this study in primary care practices, taking warfarin in the morning was similar to taking it in the evening for maintaining anticoagulation. The study was designed to assess differences in therapeutic time in range, but it was not powered to detect differences in clinical events. 1b-
Reference
Study design: Randomized controlled trial (single-blinded)
Funding: Foundation
Setting: Outpatient (primary care)
Synopsis
Warfarin is typically administered at the end of the day to shorten the interval between international normalized ratio results and dosing adjustments. To figure out if there was anything more than pragmatism guiding this practice, these researchers conducted a trial in real world primary care settings in western Canada. They randomized patients who take warfarin in the evening (with at least 3 months of monitoring data and no immediate plans to stop) to either morning administration (n = 109) or continued evening administration (n = 108). Although patients knew what intervention they received (by the way, this could have been easily fixed by providing placebo doses), the outcome evaluators did not. At baseline, patients in each group spent 72% of their time in the therapeutic range (a bit higher than the 67% typically found). After 7 months, there were no significant departures from baseline trends in time in the therapeutic range. Three patients who took warfarin in the morning had an adverse event (one had gastrointestinal bleeding, one had a thromboembolic stroke, and one had a deep vein thrombosis) compared with 2 in the evening group (one had a thromboembolic stroke, and one had a deep vein thrombosis, an acute arterial occlusion, and a myocardial infarction).
Reviewer
Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI